啟明醫療-B(02500.HK)漏報11.8億人幣建造合約 續停牌
啟明醫療-B(02500.HK)公布,於2022年11月17日,公司與中建一局集團訂立建造合約,據此,中建一局集團獲委任為指定承包人,為杭州開發項目提供建造工程,固定合約總額11.82億元人民幣,並構成須予披露交易,但違規未有及時披露。
公司指,事件於內部審閱公司重要合約時方被發現,公司已於知悉該交易後安排在切實可行情況下盡快刊發公告。為防止同類事件於日後再度發生,公司已委任德勤企業諮詢(上海)有限公司北京分公司作為內部控制顧問,以就公司須予披露交易相關的內部控制政策之制定及實施進行審查並發現不足,根據不足之處提出建議,進一步審查公司的補救措施並於進一步審查後出具最終報告;公司的合規顧問將至少每月一次向公司管理層發出提示及問卷,藉此緊貼集團任何重大交易的進度,以便提前妥善規劃合規工作;公司審核委員會將獲授權負責審查並改進公司的內部控制系統及財務報告系統。
另外,集團將向董事、集團高級管理層級相關僱員發出相關指引及培訓資料,亦將安排有關遵守須予公布及關連交易規定之培訓課程;公司將不時及在必要時尋求法律意見及/或其他專業建議,以確保集團妥善遵守上市規則之相關規定。
公司股份自2023年11月23日上午九時正起於聯交所暫停買賣,並將繼續暫停買賣以待達成聯交所規定的復牌指引。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.